Paralel Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6M Sell
10,932
-8,485
-44% -$1.76M 0.1% 54
2026
Q1
$4.1M Hold
19,417
0.17% 32
2025
Q4
$3.99M Hold
19,417
0.16% 33
2025
Q3
$3.05M Buy
19,417
+25
+0.1% +$3.86K 0.12% 44
2025
Q2
$3.26M Sell
19,392
-3,091
-14% -$459K 0.13% 32
2025
Q1
$3.1M Hold
22,483
0.13% 37
2024
Q4
$2.66M Buy
22,483
+2,040
+10% +$238K 0.11% 52
2024
Q3
$2.26M Hold
20,443
0.1% 70
2024
Q2
$2.01M Buy
+20,443
New +$2.08M 0.1% 75
2023
Q2
Sell
-32,030
Closed -$2.42M 83
2023
Q1
$2.42M Buy
32,030
+842
+3% +$63.5K 0.14% 26
2022
Q4
$2.4M Buy
+31,188
New +$2.37M 0.14% 22

Other funds holding CAH

Paralel Advisors's CAH Position: Q2 2026 in Review

Paralel Advisors reduced its Cardinal Health (CAH) stake by 44% in Q2 2026, selling an estimated $1.76M and leaving 10,932 shares worth $2.6M. The position accounts for 0.1% of the portfolio, ranked #54.

Paralel Advisors first reported a position in CAH in Q4 2022 and has held it in 11 quarters since. The position peaked at $4.1M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Paralel Advisors held 10,932 shares of Cardinal Health worth $2.6M as of Q2 2026.
  • Paralel Advisors sold 8,485 Cardinal Health shares in Q2 2026, an estimated $1.76M.
  • Cardinal Health made up 0.1% of Paralel Advisors's portfolio in Q2 2026, its #54 holding.
  • Paralel Advisors first reported a position in Cardinal Health in Q4 2022 and has held it in 11 quarters since.
  • Paralel Advisors's Cardinal Health position peaked at $4.1M in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Paralel Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.